Anixter International Inc (AXE) 77.58 $AXE Insider

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 1:31 AM

Anixter International Inc (AXE) 77.58 $AXE

Insider Trading Alert - EWBC, IPHS And AXE Traded By Insiders
at The Street - Thu Mar 19, 9:43AM CDT
Stocks with insider trader activity include EWBC, IPHS and AXE
EWBC: 41.13 (+0.33), AXE: 77.58 (+0.91), IPHS: 57.62 (+1.45)

Anixter International (AXE) Upgraded From Hold to Buy
at The Street - Tue Mar 17, 9:20AM CDT
Anixter International (AXE) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
AXE: 77.58 (+0.91)

Anixter International Shares Down 11.3% Since SmarTrend's Sell Call (AXE)
Comtex SmarTrend(R) - Thu Feb 12, 4:54PM CST
SmarTrend identified a Downtrend for Anixter International (NYSE:AXE) on January 9th, 2015 at $85.24. In approximately 1 month, Anixter International has returned 11.28% as of today's recent price of $75.63.
AXE: 77.58 (+0.91)

Anixter International Inc. to Sell Its Fasteners Segment to American Industrial Partners for $380 Million
Business Wire - Thu Feb 12, 7:30AM CST
Anixter International Inc. (NYSE: AXE) today announced that it has entered into a definitive agreement to sell its OEM Supply - Fasteners ("Fasteners"

segment to American Industrial Partners ("AIP"

for $380 million in cash, subject to certain post-closing adjustments. The transaction, which was approved by Anixter's Board of Directors, is expected to close during the second quarter of 2015, subject to customary closing conditions and regulatory approval.
AXE: 77.58 (+0.91)

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
AXE: 77.58 (+0.91), BIO: 134.98 (-1.35), BCE: 42.17 (+0.12), BITA: 53.08 (+2.25)

Downtrend Call Working As Anixter International Stock Falls 12.4% (AXE)
Comtex SmarTrend(R) - Thu Feb 05, 11:17AM CST
SmarTrend identified a Downtrend for Anixter International (NYSE:AXE) on January 9th, 2015 at $85.25. In approximately 4 weeks, Anixter International has returned 12.42% as of today's recent price of $74.65.
AXE: 77.58 (+0.91)

Anixter International (AXE) Downgraded From Buy to Hold
at The Street - Thu Feb 05, 9:20AM CST
Anixter International (AXE) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AXE: 77.58 (+0.91)

Update: Anixter International Q4 2014 Earnings
Mark Lin - at Seeking Alpha - Wed Feb 04, 3:14AM CST

AXE: 77.58 (+0.91)

Anixter International's (AXE) CEO Robert Eck on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 4:14PM CST

AXE: 77.58 (+0.91)

Anixter International (AXE) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 03, 9:25AM CST

AXE: 77.58 (+0.91)

Anixter International misses Street 4Q forecasts
Automated Insights - Tue Feb 03, 7:06AM CST
GLENVIEW, Ill. (AP) _ Anixter International Inc. (AXE) on Tuesday reported fourth-quarter profit of $41.1 million.
AXE: 77.58 (+0.91)

Anixter International misses by $0.20, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 6:35AM CST

AXE: 77.58 (+0.91)

Anixter International Inc. Reports Fourth Quarter 2014 Results
Business Wire - Tue Feb 03, 6:30AM CST
--Fourth Quarter Highlights
AXE: 77.58 (+0.91)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:30PM CST

CEVA: 21.74 (+0.21), HCLP: 36.41 (+1.41), PNR: 64.64 (+0.26), AET: 108.63 (+0.32), HW: 18.00 (+0.50), UPS: 100.25 (+0.34), NOV: 49.66 (+1.77), JLL: 169.56 (+5.10), ST: 57.45 (+0.54), LYB: 85.53 (+0.51), ACI: 0.90 (-0.05), R: 98.00 (+1.01), TECH: 101.15 (+0.62), SPR: 52.01 (+0.26), BP: 40.10 (+1.13), NYT: 13.78 (+0.04), WDR: 50.56 (+1.29), HRC: 48.01 (-0.31), MNK: 132.47 (+1.26), SC: 23.07 (-0.27), CHD: 86.14 (+0.80), ETN: 68.48 (+0.90), BHE: 24.82 (+0.41), ARG: 107.28 (-5.73), AGCO: 47.58 (+0.26), EMR: 56.69 (+0.42), GLPI: 37.65 (+0.94), CNC: 70.25 (-0.34), HCA: 76.03 (+0.61), MHO: 23.11 (+0.62), CARB: 14.35 (+0.04), AXE: 77.58 (+0.91), IMS: 26.71 (+0.18), GCI: 36.39 (+0.14), LPT: 37.13 (+0.88), CBR: 4.06 (+0.05), ARRY: 8.00 (-0.09), AN: 63.49 (+0.10)

Anixter International to Release Fourth Quarter 2014 Financial Results and Host Investor Conference Call on Tuesday, February 3, 2015
Business Wire - Tue Jan 20, 6:30AM CST
Anixter International Inc. (NYSE: AXE) will release its fourth quarter 2014 results on Tuesday, February 3, 2015, before the opening of the New York Stock Exchange. The company will host a conference call to discuss these results beginning at 9:30 a.m. central time. The call will be available as a live audio webcast and can be accessed at the investor relations portion of Anixter's website at www.anixter.com/investor.
AXE: 77.58 (+0.91)

Downgrade Alert for Anixter International (AXE)
Comtex SmarTrend(R) - Fri Jan 09, 8:05AM CST
Anixter International (NYSE:AXE) was downgraded from Buy to Hold at BB&T Capital today. The stock closed yesterday at $86.98 on volume of 220,000 shares, above average daily volume of 200,000. Anixter International (NYSE:AXE) has potential upside of 9.5% based on a current price of $86.98 and analysts' consensus price target of $95.20. Anixter International shares should encounter resistance at the 200-day moving average (MA) of $91.37 and support at the 50-day MA of $85.98.
AXE: 77.58 (+0.91)

Anixter International: Pessimism Fuels An Attractive Contrarian Opportunity
Saibus Research - at Seeking Alpha - Wed Jan 07, 11:13PM CST

AXE: 77.58 (+0.91)

Anixter International: No Suitor Could Be Found
Alpha Gen Capital - at Seeking Alpha - Sat Dec 27, 9:55AM CST

AXE: 77.58 (+0.91), RXL: 149.91 (+1.63)

How it All Plays Out: New Report on Ambev, Amira Nature Foods, Anheuser-Busch Inbev, Anixter and AptarGroup
PR Newswire - Mon Dec 22, 6:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Ambev (NYSE: ABEV), Amira Nature Foods (NYSE: ANFI), Anheuser-Busch Inbev (NYSE: BUD), Anixter (NYSE: AXE), and AptarGroup (NYSE: ATR). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
BUD: 122.85 (+1.40), AXE: 77.58 (+0.91), ABEV: 5.82 (+0.20), ATR: 63.23 (-0.41), ANFI: 9.66 (-0.15)

North American Intrauterine Contraceptive Devices Micro Market Monitor 2014-2019
M2 - Wed Dec 17, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/jh6m2r/micro_market) has announced the addition of the "Micro Market Monitor: North American Intrauterine Contraceptive Devices Market" report to their offering. The North American perimeter security market is estimated to grow at a CAGR of 3.6% from 2014 to 2019 Although the U.S. market holds a larger share in this market, Canada is expected to grow at a higher CAGR of 7.9% in the forecast period. The growth of the perimeter security market in North America is driven by factors such as need for security against terrorist activities, government regulations, technological developments, and the requirement to reduce the cost of manpower. However, the economic slowdown in the region has proven to be a hurdle in the growth of the perimeter security solutions market. Most industries and organizations are reluctant to install perimeter security as a result of their unwillingness to incur additional costs for such high-end security solutions. The critical infrastructure vertical has the highest share in the perimeter security market because the protection of critical entities such as nuclear power plants is of immense importance to the national security of a country. However, commercial facilities and sensitive areas have the highest growth rate of 6.4% from 2014 to 2019, as these verticals are expected to deploy perimeter security systems on a large scale in coming years. In North America, the trend involving the verification of intrusion alarms with the help of video technology is driving the market for video surveillance systems in the region. The spending on sensors is expected to remain the backbone of perimeter security solutions. However, the spending on video & intelligence analytics will continue to be greater than the spending on sensors, for all verticals. System integration and consulting services are expected to have a higher market share in the perimeter security market during the forecast period. Scope of the Report - System (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) - Vertical (Critical infrastructure, Defense & Government, Transportation Facilities, Sensitive Areas, Commercial Facilities) - Deployment type (Open Area, Fence Mounted, Buried) Key Topics Covered: 1 Introduction 2 Research Methodology 3.1 Abstract 4 Market Overview 5 North America Perimeter Security Market, By Components 6 North America Perimeter Security, By Vertical 7 North America Perimeter Security Market: Competitive Landscape 8 Company Profiles - Anixter International - Axis Communications Ab - Honeywell International, Inc - Senstar - Xtralis For more information visit http://www.researchandmarkets.com/research/jh...cro_market
AXE: 77.58 (+0.91), HON: 105.40 (+2.38)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...